Tim McInerney brings over 30 years of experience as a pharmaceutical executive and healthcare investment banker and analyst with positions in industry and a number of Wall Street firms. Following positions at Bristol, Myers Squibb, Bear Stearns, Shearson Lehman Brothers and Ladenburg Thalmann, Tim oversaw the overall distribution of Paramount Capital Group’s private equity product and was directly responsible for over $1B in capital raised for both startups and private placement investments.
In the early stage financings of Cougar Biotech (acquired by J&J), Kite Pharma, Velcera (acquired by Perrigo) and Ziopharm Oncology, Tim played a significant role. He has served on numerous public and private boards including, chairman of InSite Vision (acquired by Sun Pharmaceuticals) and Edgemont Pharmaceuticals (acquired by Alvogen, Inc.) and currently serves on the boards of Adgero Biopharmaceuticals, Emisphere Technologies and QSpex Technologies Inc. He also is a co-founding investor and board member of Corino Therapeutics and the sole managing member of Texas Oncology Investments, LLC.
Mr. McInerney received his BS in Pharmacy from St. John’s University in 1983 and also completed a post-graduate residency in drug information systems at the New York University Medical Center.